Article
Weight and Glycemic Control Outcomes of Bariatric Surgery and Pharmacotherapy in Patients With Melanocortin-4 Receptor Deficiency.
Frontiers in endocrinology - 1 Jan 2021
Fojas Esphie Grace Fodra, Radha Saradalekshmi Koramannil, Ali Tomader, Nadler Evan P, Lessan Nader
Abstract excerpt
Background: Melanocortin-4 receptor (MC4R) mutations are the most common of the rare monogenic forms of obesity. However, the efficacy of bariatric surgery (BS) and pharmacotherapy on weight and glycemic control in individuals with MC4R deficiency (MC4R-d) is not well-established. We investigated and compared the outcomes of BS and pharmacotherapy in patients with and without MC4R-d. Methods: Pertinent details...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
